(Q35142594)

6 August 2017

1 reference

title

Complement C4d in graft capillaries -- the missing link in the recognition of humoral alloreactivity (English)

1 reference

6 August 2017

Helmut E Feucht

1

1 reference

PubMed ID

12780555

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

American Journal of Transplantation

6 August 2017

1 reference

6 August 2017

3

1 reference

6 August 2017

6

1 reference

6 August 2017

646-652

1 reference

Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells

6 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

X-ray crystal structure of the C4d fragment of human complement component C4

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

Tortuosity of the white matter medullary arterioles is related to the severity of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

Linear C3 deposits on the tubular basement membrane in renal allograft biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

Peri-operative immunoadsorption in sensitized renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

Local synthesis of complement component C3 regulates acute renal transplant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

Anti-HLA antibodies after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

CD4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

The humoral immune response towards HLA class II determinants in renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

Classical pathway of complement activation in normal and diseased human glomeruli

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

Capillary deposition of C4d complement fragment and early renal graft loss

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

Assessment of soluble adhesion molecules (sICAM-1, sVCAM-1, sELAM-1) and complement cleavage products (sC4d, sC5b-9) in urine. Clinical monitoring of renal allograft recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

Early renal graft dysfunction. The role of preformed antibodies to DR-typed lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

Kidney graft failure and presensitization against HLA class I and class II antigens

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

Unusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

Antibodies directed against antigens on the endothelium of peritubular capillaries in patients with rejecting renal allografts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

C4d and the fate of organ allografts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

The clinical significance of allospecific antibodies against endothelial cells detected with an antibody-dependent cellular cytotoxicity assay for vascular rejection and graft loss after renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

Complement causes allograft injury by cell activation rather than lysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00171.X

7 January 2021

10.1034/J.1600-6143.2003.00171.X

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12780555